Houston Methodist Research Institute is collaborating with the Coalition for Epidemic Preparedness Innovations and leading scientific institutions in the Republic of Korea to develop what could become the world’s first mRNA vaccine against severe fever with thrombocytopenia syndrome, a tick-borne viral disease associated with this condition.
[Houston Methodist Research Institute]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News